Oxford Asset Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Oxford Asset Management’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-282,885	Closed	-$2.3M	–	1056
2019 Q4	$2.3M	Sell	282,885 -34,125	-11%	-$269K	0.06%	344
2019 Q3	$2.4M	Sell	317,010 -208,920	-40%	-$1.55M	0.06%	445
2019 Q2	$3.94M	Buy	525,930 +134,110	+34%	+$1.05M	0.08%	341
2019 Q1	$3.17M	Buy	+391,820	New	+$2.98M	0.07%	367
2018 Q3	–	Sell	-233,845	Closed	-$1.5M	–	1888
2018 Q2	$1.5M	Buy	233,845 +174,065	+291%	+$1.1M	0.03%	830
2018 Q1	$391K	Buy	+59,780	New	+$419K	0.01%	1330
2017 Q3	–	Sell	-161,420	Closed	-$1.36M	–	1670
2017 Q2	$1.36M	Sell	161,420 -74,300	-32%	-$604K	0.03%	781
2017 Q1	$1.89M	Buy	235,720 +117,045	+99%	+$1.01M	0.05%	508
2016 Q4	$1.07M	Buy	+118,675	New	+$1.1M	0.04%	459
2014 Q1	–	Sell	-241,235	Closed	-$1.98M	–	741
2013 Q4	$1.98M	Buy	+241,235	New	+$1.91M	0.05%	423
2013 Q3	–	Sell	-339,865	Closed	-$2.57M	–	883
2013 Q2	$2.57M	Buy	+339,865	New	+$2.48M	0.07%	411

Other funds holding RDY

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Aperio Group Sausalito, California $33.8B AUM 31.46% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $44.4B AUM 36.05% 1-Year Est. Return

Oxford Asset Management's RDY Position: Q1 2020 in Review

Oxford Asset Management sold out of Dr. Reddy's Laboratories (RDY) in Q1 2020, closing a stake of 282,885 shares — an estimated $2.3M sold.

Oxford Asset Management first reported a position in RDY in Q2 2013 and held it in 11 quarters. The position peaked at $3.94M in Q2 2019. 148 funds tracked by Wall St. Rank hold RDY as of Q1 2020.

Oxford Asset Management reported no remaining Dr. Reddy's Laboratories position as of Q1 2020 after selling out during the quarter.
Oxford Asset Management sold 282,885 Dr. Reddy's Laboratories shares in Q1 2020, an estimated $2.3M.
Oxford Asset Management first reported a position in Dr. Reddy's Laboratories in Q2 2013 and held it in 11 quarters.
Oxford Asset Management's Dr. Reddy's Laboratories position peaked at $3.94M in Q2 2019.
148 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.